table of content
1 Introduction to Research & Analysis Reports
1.1 Tumor Biomarker Test Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tumor Biomarker Test Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tumor Biomarker Test Overall Market Size
2.1 Global Tumor Biomarker Test Market Size: 2022 VS 2030
2.2 Global Tumor Biomarker Test Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Tumor Biomarker Test Players in Global Market
3.2 Top Global Tumor Biomarker Test Companies Ranked by Revenue
3.3 Global Tumor Biomarker Test Revenue by Companies
3.4 Top 3 and Top 5 Tumor Biomarker Test Companies in Global Market, by Revenue in 2022
3.5 Global Companies Tumor Biomarker Test Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tumor Biomarker Test Players in Global Market
3.6.1 List of Global Tier 1 Tumor Biomarker Test Companies
3.6.2 List of Global Tier 2 and Tier 3 Tumor Biomarker Test Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Tumor Biomarker Test Market Size Markets, 2022 & 2030
4.1.2 Prostate Specific Antigen Tests
4.1.3 CTC Tests
4.1.4 Alpha-Fetoprotein (AFP) Tests
4.1.5 CA Test
4.1.6 HER2 Tests
4.1.7 BRCA Test
4.1.8 Anaplastic Lymphoma Kinase (ALK) Tests
4.1.9 EGFR Mutation Tests
4.1.10 KRAS Test
4.1.11 Others
4.2 By Type - Global Tumor Biomarker Test Revenue & Forecasts
4.2.1 By Type - Global Tumor Biomarker Test Revenue, 2018-2023
4.2.2 By Type - Global Tumor Biomarker Test Revenue, 2024-2030
4.2.3 By Type - Global Tumor Biomarker Test Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tumor Biomarker Test Market Size, 2022 & 2030
5.1.2 Lung cancer
5.1.3 Breast cancer
5.1.4 Colorectal
5.1.5 Prostate Cancer
5.1.6 Blood Cancer
5.2 By Application - Global Tumor Biomarker Test Revenue & Forecasts
5.2.1 By Application - Global Tumor Biomarker Test Revenue, 2018-2023
5.2.2 By Application - Global Tumor Biomarker Test Revenue, 2024-2030
5.2.3 By Application - Global Tumor Biomarker Test Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Tumor Biomarker Test Market Size, 2022 & 2030
6.2 By Region - Global Tumor Biomarker Test Revenue & Forecasts
6.2.1 By Region - Global Tumor Biomarker Test Revenue, 2018-2023
6.2.2 By Region - Global Tumor Biomarker Test Revenue, 2024-2030
6.2.3 By Region - Global Tumor Biomarker Test Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Tumor Biomarker Test Revenue, 2018-2030
6.3.2 US Tumor Biomarker Test Market Size, 2018-2030
6.3.3 Canada Tumor Biomarker Test Market Size, 2018-2030
6.3.4 Mexico Tumor Biomarker Test Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Tumor Biomarker Test Revenue, 2018-2030
6.4.2 Germany Tumor Biomarker Test Market Size, 2018-2030
6.4.3 France Tumor Biomarker Test Market Size, 2018-2030
6.4.4 U.K. Tumor Biomarker Test Market Size, 2018-2030
6.4.5 Italy Tumor Biomarker Test Market Size, 2018-2030
6.4.6 Russia Tumor Biomarker Test Market Size, 2018-2030
6.4.7 Nordic Countries Tumor Biomarker Test Market Size, 2018-2030
6.4.8 Benelux Tumor Biomarker Test Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Tumor Biomarker Test Revenue, 2018-2030
6.5.2 China Tumor Biomarker Test Market Size, 2018-2030
6.5.3 Japan Tumor Biomarker Test Market Size, 2018-2030
6.5.4 South Korea Tumor Biomarker Test Market Size, 2018-2030
6.5.5 Southeast Asia Tumor Biomarker Test Market Size, 2018-2030
6.5.6 India Tumor Biomarker Test Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Tumor Biomarker Test Revenue, 2018-2030
6.6.2 Brazil Tumor Biomarker Test Market Size, 2018-2030
6.6.3 Argentina Tumor Biomarker Test Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Tumor Biomarker Test Revenue, 2018-2030
6.7.2 Turkey Tumor Biomarker Test Market Size, 2018-2030
6.7.3 Israel Tumor Biomarker Test Market Size, 2018-2030
6.7.4 Saudi Arabia Tumor Biomarker Test Market Size, 2018-2030
6.7.5 UAE Tumor Biomarker Test Market Size, 2018-2030
7 Tumor Biomarker Test Companies Profiles
7.1 Abbott Laboratories, Inc.
7.1.1 Abbott Laboratories, Inc. Company Summary
7.1.2 Abbott Laboratories, Inc. Business Overview
7.1.3 Abbott Laboratories, Inc. Tumor Biomarker Test Major Product Offerings
7.1.4 Abbott Laboratories, Inc. Tumor Biomarker Test Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories, Inc. Key News & Latest Developments
7.2 Agilent Technologies
7.2.1 Agilent Technologies Company Summary
7.2.2 Agilent Technologies Business Overview
7.2.3 Agilent Technologies Tumor Biomarker Test Major Product Offerings
7.2.4 Agilent Technologies Tumor Biomarker Test Revenue in Global Market (2018-2023)
7.2.5 Agilent Technologies Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Tumor Biomarker Test Major Product Offerings
7.3.4 AstraZeneca Tumor Biomarker Test Revenue in Global Market (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Becton Dickinson & Co.
7.4.1 Becton Dickinson & Co. Company Summary
7.4.2 Becton Dickinson & Co. Business Overview
7.4.3 Becton Dickinson & Co. Tumor Biomarker Test Major Product Offerings
7.4.4 Becton Dickinson & Co. Tumor Biomarker Test Revenue in Global Market (2018-2023)
7.4.5 Becton Dickinson & Co. Key News & Latest Developments
7.5 Biocept Inc.
7.5.1 Biocept Inc. Company Summary
7.5.2 Biocept Inc. Business Overview
7.5.3 Biocept Inc. Tumor Biomarker Test Major Product Offerings
7.5.4 Biocept Inc. Tumor Biomarker Test Revenue in Global Market (2018-2023)
7.5.5 Biocept Inc. Key News & Latest Developments
7.6 Cancer Genetics Inc.
7.6.1 Cancer Genetics Inc. Company Summary
7.6.2 Cancer Genetics Inc. Business Overview
7.6.3 Cancer Genetics Inc. Tumor Biomarker Test Major Product Offerings
7.6.4 Cancer Genetics Inc. Tumor Biomarker Test Revenue in Global Market (2018-2023)
7.6.5 Cancer Genetics Inc. Key News & Latest Developments
7.7 Danaher Corporation
7.7.1 Danaher Corporation Company Summary
7.7.2 Danaher Corporation Business Overview
7.7.3 Danaher Corporation Tumor Biomarker Test Major Product Offerings
7.7.4 Danaher Corporation Tumor Biomarker Test Revenue in Global Market (2018-2023)
7.7.5 Danaher Corporation Key News & Latest Developments
7.8 Foundation Medicine Inc.
7.8.1 Foundation Medicine Inc. Company Summary
7.8.2 Foundation Medicine Inc. Business Overview
7.8.3 Foundation Medicine Inc. Tumor Biomarker Test Major Product Offerings
7.8.4 Foundation Medicine Inc. Tumor Biomarker Test Revenue in Global Market (2018-2023)
7.8.5 Foundation Medicine Inc. Key News & Latest Developments
7.9 Illumina Inc.
7.9.1 Illumina Inc. Company Summary
7.9.2 Illumina Inc. Business Overview
7.9.3 Illumina Inc. Tumor Biomarker Test Major Product Offerings
7.9.4 Illumina Inc. Tumor Biomarker Test Revenue in Global Market (2018-2023)
7.9.5 Illumina Inc. Key News & Latest Developments
7.10 LabCorp Of America Holdings
7.10.1 LabCorp Of America Holdings Company Summary
7.10.2 LabCorp Of America Holdings Business Overview
7.10.3 LabCorp Of America Holdings Tumor Biomarker Test Major Product Offerings
7.10.4 LabCorp Of America Holdings Tumor Biomarker Test Revenue in Global Market (2018-2023)
7.10.5 LabCorp Of America Holdings Key News & Latest Developments
7.11 Luminex Corporation
7.11.1 Luminex Corporation Company Summary
7.11.2 Luminex Corporation Business Overview
7.11.3 Luminex Corporation Tumor Biomarker Test Major Product Offerings
7.11.4 Luminex Corporation Tumor Biomarker Test Revenue in Global Market (2018-2023)
7.11.5 Luminex Corporation Key News & Latest Developments
7.12 Myriad Genetics Inc.
7.12.1 Myriad Genetics Inc. Company Summary
7.12.2 Myriad Genetics Inc. Business Overview
7.12.3 Myriad Genetics Inc. Tumor Biomarker Test Major Product Offerings
7.12.4 Myriad Genetics Inc. Tumor Biomarker Test Revenue in Global Market (2018-2023)
7.12.5 Myriad Genetics Inc. Key News & Latest Developments
7.13 NanoString Technologies Inc.
7.13.1 NanoString Technologies Inc. Company Summary
7.13.2 NanoString Technologies Inc. Business Overview
7.13.3 NanoString Technologies Inc. Tumor Biomarker Test Major Product Offerings
7.13.4 NanoString Technologies Inc. Tumor Biomarker Test Revenue in Global Market (2018-2023)
7.13.5 NanoString Technologies Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
